Business Daily from THE HINDU group of publications
Friday, Jun 20, 2008
ePaper | Mobile/PDA Version | Audio
Business Daily from THE HINDU group of publications Friday, Jun 20, 2008 ePaper | Mobile/PDA Version | Audio |
|
|
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Aurobindo Pharma Q4 net dips marginally Our Bureau Hyderabad, June 19 Aurobindo Pharma’s net profit declined marginally at Rs 76 crore in the fourth quarter ended March 31, 2008 compared with Rs 78 crore in the corresponding quarter of previous fiscal. Total income, however, increased to Rs 641 crore (Rs 525 crore). The drop in the quarter under review was due to increase in other expenses, among others. For the full year, the Hyderabad-based company’s net profit increased 18.7 per cent to Rs 238.5 crore (Rs 201 crore) due to significant increase in formulations sales at Rs 1,005 crore (Rs 694 crore). Total income grew by 16.5 per cent to Rs 2,530 crore (Rs 2,172 crore). During the year, the company could increase its market share in the US and Europe which resulted in increased sales at $59 million ($39 million) and $50 million ($32 million) respectively. “The growth in the US and Europe is heartening considering the competitive pressure,” the company said in a release. The Chinese operations were stabilised as the Pen-G prices were continued to be stable. It filed 46 Abbreviated New Drug Applications (ANDAs) in the US taking its cumulative filings to 128. More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
 |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|